🌍 Global Exporter & Bulk Supplier: Sunitcap 50 mg Capsule

Introduction

Looking for a certified and reliable global partner for high-strength oncology medications? Ernest Oncology (a premier division of Ernest Pharmaceutical Pvt. Ltd.) is a leading international exporter and bulk supplier of Sunitcap 50 mg Capsules.

We specialize in maintaining a high-quality, temperature-controlled supply chain for Sunitinib 50 mg, serving hospitals, clinics, and pharmaceutical wholesalers across the USA, UK, Australia, and South Africa.

🔬 Product Overview

Sunitcap 50 mg is a higher-strength formulation of Sunitinib, a potent multi-targeted tyrosine kinase inhibitor (TKI). It is an essential component in modern oncology for blocking growth signals in cancer cells.

• Active Ingredient: Sunitinib (50 mg)

• Therapeutic Class: Antineoplastic Agent / Tyrosine Kinase Inhibitor

• Primary Indications:

  • Advanced Renal Cell Carcinoma (RCC)

  • Gastrointestinal Stromal Tumors (GIST)

  • Pancreatic Neuroendocrine Tumors (pNET)

📦 Why Source from Ernest Oncology?

• Global Reach: Dedicated export channels to the USA, UK, Australia, and South Africa.

• Bulk Supply Excellence: Large-scale stock availability for hospital tenders and wholesale requirements.

• Quality Standards: Sourced through validated pharmaceutical channels following global safety protocols.

• Professional Logistics: Comprehensive documentation support and specialized handling for international shipping.

PRESCRIPTION MEDICINE IS : YES

⚠️  Disclaimer

Sunitcap 50 mg Capsule is a high-potency prescription medication. It must only be used under the direct supervision of a qualified oncologist. This post is for B2B informational purposes and pharmaceutical trade only; it does not replace professional medical advice.

📞 Contact Ernest Oncology — Global Medicine Exporter